Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision Next revision | Previous revision Next revision Both sides next revision | ||
|
publications [2020/01/10 10:04] ramirez [2018] |
publications [2020/01/21 10:37] ramirez [2019] |
||
|---|---|---|---|
| Line 8: | Line 8: | ||
| Hänscheid T, Schlagenhauf P, Grobusch MP. 2019. Atovaquone/proguanil for malaria chemoprophylaxis - Could a difference in susceptibility during hepatic development explain the need to continue drug intake for 7 days post-exposure? Travel Med Infect Dis 101527. [[http://www.ncbi.nlm.nih.gov/pubmed/31759143|(PMID: 31759143)]] | Hänscheid T, Schlagenhauf P, Grobusch MP. 2019. Atovaquone/proguanil for malaria chemoprophylaxis - Could a difference in susceptibility during hepatic development explain the need to continue drug intake for 7 days post-exposure? Travel Med Infect Dis 101527. [[http://www.ncbi.nlm.nih.gov/pubmed/31759143|(PMID: 31759143)]] | ||
| - | |||
| - | van der Linden M, Mamede R, Levina N, Helwig P, Vila-Cerqueira P, Carriço JA, [[people:jmelocristino|Melo-Cristino J]], [[people:ramirez|Ramirez M]], [[people:emartins|Martins ER]]. 2019. <fc #0000FF>Heterogeneity of penicillin-non-susceptible group B streptococci isolated from a single patient in Germany</fc>. J Antimicrob Chemother. //In press//. [[http://www.ncbi.nlm.nih.gov/pubmed/31740946|(PMID: 31740946)]] | ||
| Duque-Valencia J, Forero-Muñoz NR, Díaz FJ, [[people:emartins|Martins E]], Barato P, Ruiz-Saenz J. 2019. <fc #0000FF>Phylogenetic evidence of the intercontinental circulation of a canine distemper virus lineage in the Americas</fc>. Sci Rep 9:15747. [[http://www.ncbi.nlm.nih.gov/pubmed/31673120|(PMID: 31673120)]] | Duque-Valencia J, Forero-Muñoz NR, Díaz FJ, [[people:emartins|Martins E]], Barato P, Ruiz-Saenz J. 2019. <fc #0000FF>Phylogenetic evidence of the intercontinental circulation of a canine distemper virus lineage in the Americas</fc>. Sci Rep 9:15747. [[http://www.ncbi.nlm.nih.gov/pubmed/31673120|(PMID: 31673120)]] | ||
| Line 37: | Line 35: | ||
| Björnsdóttir ES, [[people:emartins|Martins ER]], Erlendsdóttir H, Haraldsson G, [[people:jmelocristino|Melo-Cristino J]], [[people:ramirez|Ramirez M]], Kristinsson KG. 2019. <fc #0000FF>Group B streptococcal neonatal and early infancy infections in Iceland 1976 - 2015</fc>. Pediatr Infect Dis J. 38:620–624. [[http://www.ncbi.nlm.nih.gov/pubmed/30299423|(PMID: 30299423)]] | Björnsdóttir ES, [[people:emartins|Martins ER]], Erlendsdóttir H, Haraldsson G, [[people:jmelocristino|Melo-Cristino J]], [[people:ramirez|Ramirez M]], Kristinsson KG. 2019. <fc #0000FF>Group B streptococcal neonatal and early infancy infections in Iceland 1976 - 2015</fc>. Pediatr Infect Dis J. 38:620–624. [[http://www.ncbi.nlm.nih.gov/pubmed/30299423|(PMID: 30299423)]] | ||
| - | Huizenga E, van der Ende J, Zwinkels N, Jimissa A, van der Ende-Bouwman C, van Rooijen R, Kargbo B, Agnandji ST, Hänscheid T, Goorhuis A, Grobusch MP. 2018. <fc #0000FF>A modified case definition to facilitate essential hospital care during Ebola outbreaks</fc>. Clin Infect Dis. 68:1763–1768. [[http://www.ncbi.nlm.nih.gov/pubmed/30239602|(PMID: 30239602)]] | + | Huizenga E, van der Ende J, Zwinkels N, Jimissa A, van der Ende-Bouwman C, van Rooijen R, Kargbo B, Agnandji ST, Hänscheid T, Goorhuis A, Grobusch MP. 2019. <fc #0000FF>A modified case definition to facilitate essential hospital care during Ebola outbreaks</fc>. Clin Infect Dis. 68:1763–1768. [[http://www.ncbi.nlm.nih.gov/pubmed/30239602|(PMID: 30239602)]] |
| + | |||
| + | Hänscheid T, Grobusch MP. 2019. <fc #0000FF>Could antibiotic treatment of traveller’s diarrhoea even prolong elimination of pathogens?</fc> Travel Med Infect Dis. 28:104. [[http://www.ncbi.nlm.nih.gov/pubmed/30030070|(PMID: 30030070)]] | ||
| ===== 2018 ===== | ===== 2018 ===== | ||
| Caneiras C, Calisto F, Jorge da Silva G, Lito L, [[people:jmelocristino|Melo-Cristino J]], Duarte A. 2018. <fc #0000FF>First description of colistin and tigecycline-resistant //Acinetobacter baumannii// producing KPC-3 carbapenemase in Portugal</fc>. Antibiotics 7. [[https://doi.org/10.3390/antibiotics7040096|doi:10.3390/antibiotics7040096]] [[http://www.ncbi.nlm.nih.gov/pubmed/30404152|(PMID: 30404152)]] | Caneiras C, Calisto F, Jorge da Silva G, Lito L, [[people:jmelocristino|Melo-Cristino J]], Duarte A. 2018. <fc #0000FF>First description of colistin and tigecycline-resistant //Acinetobacter baumannii// producing KPC-3 carbapenemase in Portugal</fc>. Antibiotics 7. [[https://doi.org/10.3390/antibiotics7040096|doi:10.3390/antibiotics7040096]] [[http://www.ncbi.nlm.nih.gov/pubmed/30404152|(PMID: 30404152)]] | ||